Company Legal Name
Latest Valuation
Founded Year
Headquarter
AlphaSense Inc. operates a leading AI-powered research platform that enables investment professionals and business analysts to extract actionable insights from vast repositories of financial documents, earnings calls, research reports, and market data. Founded in 2011 and headquartered in New York, the company has established itself as a critical infrastructure provider for the global investment research ecosystem, serving institutional investors, corporations, and financial services firms. With a current valuation of $4 billion, AlphaSense has demonstrated strong market traction by transforming how professionals discover, analyze, and synthesize information for investment decisions and strategic planning across diverse industries.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





